Equity - Schedule of Common Stock Purchase Warrants Issued and Outstanding (Details) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Stockholders' Equity Note [Abstract] | ||
| Warrants Outstanding, Beginning balance | 51,066,864 | 35,087,197 |
| Warrants Outstanding, Granted | 12,250,000 | 24,829,666 |
| Warrants Outstanding, Exercised | (125,000) | (3,910,000) |
| Warrants Outstanding, Expired | (6,148,028) | (4,940,000) |
| Warrants Outstanding, Ending balance | 57,043,836 | 51,066,864 |
| Weighted Average Exercise Price, Beginning balance | $ 0.20 | $ 0.24 |
| Weighted Average Exercise Price, Granted | 0.15 | 0.11 |
| Weighted Average Exercise Price, Exercised | 0.09 | 0.09 |
| Weighted Average Exercise Price, Expired | 0.25 | 0.10 |
| Weighted Average Exercise Price, Ending balance | $ 0.14 | $ 0.20 |
| X | ||||||||||
- Definition Weighted Average Exercise Price, Expired. No definition available.
|
| X | ||||||||||
- Definition Warrants Weighted Average Exercise Price. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price, Exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price, Granted. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|